Benefit of Adjuvant Chemotherapy and Trastuzumab in HER2+ Node-Negative Breast Tumors ≤10 mm
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study
Breast Cancer Res Treat 2022 Sep 08;[EPub Ahead of Print], CMS Hassing, MK Mejdahl, AV Lænkholm, N Kroman, AS Knoop, THF TvedskovFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.